Literature DB >> 12822605

The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma.

J Hugo Schouwink1, Leo Schultze Kool, Emiel J Rutgers, Frans A N Zoetmulder, Nico van Zandwijk, Marc J v d Vijver, Paul Baas.   

Abstract

BACKGROUND: Patients with localized malignant pleural mesothelioma (MPM) can be considered for surgical resection with or without additional treatment. For this approach it is imperative to select patients without mediastinal lymph node involvement. In this study cervical mediastinoscopy (CM) is compared with computer tomography (CT) scanning for its diagnostic accuracy in assessing mediastinal lymph nodes during preoperative workup.
METHODS: Computer tomography scans of the chest and CM were performed in 43 patients with proven unilateral MPM. The CT scans were reviewed by one radiologist and two chest physicians. At CM the lymph node samples were taken from stations Naruke 2, 3, 4, and 7. Computer tomography and CM results were compared with final histopathologic findings obtained at thoracotomy or, if this was not performed, at CM.
RESULTS: Computer tomography scanning revealed pathologic enlarged lymph nodes with a shortest diameter of at least 10 mm in 17 of 43 patients (39%). There was histopathologic evidence of lymph node metastases at CM in 11 of these patients (26%). This resulted in a sensitivity of 60% and 80%, a specificity of 71% and 100%, and a diagnostic accuracy of 67% and 93% for CT and CM, respectively.
CONCLUSIONS: Cervical mediastinoscopy is a valuable diagnostic procedure for patients with MPM who are considered candidates for surgical-based therapy. Results of CM are more reliable than those obtained by CT scanning. Our data confirm results of previous studies reporting that mediastinal lymph node involvement is a frequent event in MPM.

Entities:  

Mesh:

Year:  2003        PMID: 12822605     DOI: 10.1016/s0003-4975(03)00010-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?

Authors:  Nico van Zandwijk; Glen Reid; Anthony Linton; Steven Kao
Journal:  Ann Cardiothorac Surg       Date:  2012-11

Review 2.  Malignant pleural mesothelioma: predictors and staging.

Authors:  William G Richards
Journal:  Ann Transl Med       Date:  2017-06

Review 3.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 4.  Malignant pleural mesothelioma.

Authors:  Siva Raja; Sudish C Murthy; David P Mason
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

5.  Mediastinoscopy: trends and practice patterns in the United States.

Authors:  Krishna S Vyas; Daniel L Davenport; Victor A Ferraris; Sibu P Saha
Journal:  South Med J       Date:  2013-10       Impact factor: 0.954

Review 6.  Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

7.  Endobronchial ultrasound-guided transbronchial needle aspiration mediastinal lymph node staging in malignant pleural mesothelioma.

Authors:  Kasia Czarnecka-Kujawa; Marc de Perrot; Shaf Keshavjee; Kazuhiro Yasufuku
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

8.  CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma.

Authors:  I Berger; Scott Simpson; J S Friedberg; Melissa J Culligan; E Paul Wileyto; Evan W Alley; D Sterman; Akash M Patel; U Khalid; C B Simone; Keith A Cengel; Sharyn I Katz; L Roshkovan
Journal:  Lung Cancer       Date:  2020-12-04       Impact factor: 5.705

9.  Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.

Authors:  A Linton; N Pavlakis; R O'Connell; M Soeberg; S Kao; S Clarke; J Vardy; N van Zandwijk
Journal:  Br J Cancer       Date:  2014-09-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.